WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: FDA PATIENT REPRESENTATIVE PROGRAM

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on FDA PATIENT REPRESENTATIVE PROGRAM

Mark Identification

Proof of use for FDA PATIENT REPRESENTATIVE PROGRAM

We do not have any records of a proof of use for FDA PATIENT REPRESENTATIVE PROGRAM at this moment.

Click here to add a proof of use for FDA PATIENT REPRESENTATIVE PROGRAM

Possible trademark infringements of FDA PATIENT REPRESENTATIVE PROGRAM

Basic Information about FDA PATIENT REPRESENTATIVE PROGRAM

Serial Number
87776021
Filing Date
30 Jan 2018
Registration Number
5707463
Registration Date
26 Mar 2019
Mark Drawing Code
4

Classifications

Declare the trademark use of FDA PATIENT REPRESENTATIVE PROGRAM on the blockchain with WikiTrademarks.io.

First use of FDA PATIENT REPRESENTATIVE PROGRAM anywhere
FDA PATIENT REPRESENTATIVE PROGRAM was first used on 30 Nov 1991 for the primary classification of goods and services, international, 035 (Advertising and business)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
035
US Codes
100; 101; 102
First use of FDA PATIENT REPRESENTATIVE PROGRAM anywhere
FDA PATIENT REPRESENTATIVE PROGRAM was first used on 30 Nov 1991 for the primary classification of goods and services, international, 041 (Education and entertainment)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
041
US Codes
100; 101; 107

Who owns FDA PATIENT REPRESENTATIVE PROGRAM?

Correspondent

Angela Y. Dai
HHS Office of the General Counsel
Bldg. 31 Room 2B 50
31 Center Drive

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on FDA PATIENT REPRESENTATIVE PROGRAM